3,803 companies
7,082 AI summaries
5,914 risk analyses
2,848 growth scores
Register free — watchlist & alerts →
🔔 Get free email alerts on Modalis Therapeutics Corporation (4883)
AI summaries of Japanese EDINET filings — in English. Free, unsubscribe anytime.
- ✓ Email alert when 4883 files its next EDINET disclosure
- ✓ AI summary · sentiment · risk · growth (JA / EN)
- ✓ Free account: watchlist & alerts on all the stocks you follow
EDINET 4883 Out of Scope
Modalis Therapeutics Corporation
Change Report ／ 2026-07-30 15:47
Covers EDINET statutory filings (TDNET timely disclosures / earnings flashes are not included).
📊 Large-shareholding (5%) report Pure investment
Holder: Evo Fund
Stake: 16.20%
Change: -1.26pp decrease
Purpose:
Pure investment. While no specific circumstances are anticipated, the first filer may provide appropriate advice to the issuer from time to time depending on the situation at hand.
🧩 5% holders of this company (2 holders · 16.58%)
Each holder’s most recent 5% filing. The sum reflects disclosed major-holder ownership, not total float.
Risk and growth scores and tags are AI-generated estimates from analyzing the disclosure. They are not guarantees of fact, nor investment advice or recommendations. Make investment decisions at your own discretion.
Track Japanese disclosures with JSIGNAL
AI summaries, risk & growth analysis, watchlist alerts and a screener for every Japanese listed company.
Start free — 30-day trial Login